China Universal Asset Management Company’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$155K	Buy	13,983 +2,391	+21%	+$30.2K	0.01%	372
2025 Q4	$192K	Sell	11,592 -843	-7%	-$12K	0.01%	347
2025 Q3	$146K	Sell	12,435 -1,587	-11%	-$16.4K	0.01%	356
2025 Q2	$134K	Buy	14,022 +307	+2%	+$1.7K	0.01%	340
2025 Q1	$86K	Sell	13,715 -784	-5%	-$4.76K	0.01%	370
2024 Q4	$118K	Buy	14,499 +1,365	+10%	+$16.9K	0.01%	375
2024 Q3	$237K	Buy	13,134 +6,257	+91%	+$87.5K	0.03%	286
2024 Q2	$70.8K	Sell	6,877 -4,112	-37%	-$42.4K	0.01%	328
2024 Q1	$117K	Buy	10,989 +4,363	+66%	+$37.1K	0.01%	356
2023 Q4	$60.5K	Buy	6,626 +5,171	+355%	+$44.6K	0.01%	349
2023 Q3	$15.1K	Buy	1,455 +738	+103%	+$10.1K	﹤0.01%	315
2023 Q2	$10.3K	Buy	717 +153	+27%	+$1.76K	﹤0.01%	316
2023 Q1	$4.03K	Buy	564 +141	+33%	+$1.24K	﹤0.01%	389
2022 Q4	$4.75K	Buy	423 +56	+15%	+$577	﹤0.01%	304
2022 Q3	$4K	Buy	+367	New	+$3.5K	﹤0.01%	307